BlossomHill Therapeutics reports 2Q loss of $23.8M
BlossomHill Therapeutics reported a 2Q loss of $23.8M.
Story updates
11:01:04 AM UTC
SquawkNews
BlossomHill Therapeutics 2Q Loss/Shr $8.75 >BLSM
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.